Advertisement

Die Kombination von Antidepressiva und Neuroleptika bei der Behandlung der Schizophrenie

  • A. Rifkin
  • S. G. Siris
Chapter

Zusammenfassung

In den letzten Jahren ist das Problem des gleichzeitigen Vorhandenseins depressiver und schizophrener Symptome komplexer geworden — oder soll man sagen interessanter aufgrund des wachsenden Interesses an sogenannten »negativen Symptomen« der Schizophrenie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andreasen, NC, Olsen S. Negative vs positive schizophrenia: Definition and validation. Arch Gen Psychiatry 1982; 39: 789–794.PubMedCrossRefGoogle Scholar
  2. Crow TJ. Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980; 280: 66–68.PubMedCentralPubMedCrossRefGoogle Scholar
  3. Csernansky JG, Lombrozo L, Gulevich GD, et al. Treatment of negative schizophrenic symptoms with alprazolam: A preliminary open-label study. J Clin Psychopharmacol 1984; 4: 349–352.PubMedCrossRefGoogle Scholar
  4. Glassman AH, Perel JM, Shostak M, et al. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 1977; 34: 197–204.PubMedCrossRefGoogle Scholar
  5. Gram I Peisby N, Ibsen I, et al Plasma levels and antidepressive effect of imipramine Clin Pharmacol Ther 1976; 19:318–324.Google Scholar
  6. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.PubMedCrossRefGoogle Scholar
  7. Mandel MR Severe JB Schooler NR, et al. Development and prediction of post-psychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 1982; 39:197–203.Google Scholar
  8. Mcglashan TH, Carpenter WT Jr. Post-psychotic depression in schizophrenia. Arch Gen Psychiatry 1976; 33: 231–241.CrossRefGoogle Scholar
  9. Putten Van T May Pra. »Akinetic depression« in schizophrenia. Arch Gen Psychiatry 1978; 35:1101–1107.Google Scholar
  10. Rifkin, A, Quitkin F, Klein DF. Akinesia. Arch Gen Psychiatry 1975; 32: 672–674.CrossRefGoogle Scholar
  11. Rifkin A, Quitkin F, Kane J, et al. Are prophylactic antiparkinson drugs necessary? Arch Gen Psychiatry 1978; 35: 483–489.PubMedCrossRefGoogle Scholar
  12. Roy A. Suicide in chronic schizophrenia. Br J Psychiatry 1982a; 141: 171–177.PubMedCrossRefGoogle Scholar
  13. Roy A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 1982b; 39: 10891095.Google Scholar
  14. Siris SG, Glassman AH, Stetner F. The value of plasma concentrations in assessing the effects of tricyclic antidepressants. In: Schooler JC, Claghorn JL, eds. Kinetics of Psychiatric Drugs. New York: Brunner-Mazel, 1979: 215–223.Google Scholar
  15. Siris SG, Harmon GK, Endicarr J. Post-psychotic depressive symptoms in hospitalized schizophrenic patients. Arch Gen Psychiatry 1981; 81: 1122–1123.CrossRefGoogle Scholar
  16. Siris SG, Kammen Van DP, Docherty JP. Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 1978; 35: 1368–1377.PubMedCrossRefGoogle Scholar
  17. Siris SG, Morgan V, Fagerstrom R, et al. Adjunctive imipramine in the treatment of post-psychotic depression: A controlled trial. Arch Gen Psychiatry 1987; 44: 533–539.PubMedCrossRefGoogle Scholar
  18. Siris SG, Rifkin A. Drug treatment of depression in patients with schizophrenia. In: RIFKIN A, ed. Schizophrenia and Depression: Biology and Drug Treatment. Boston: PSG—John Wright, 1983: 281–297.Google Scholar
  19. Siris Sg, Rifkin A, Reardon Gt, et al. The dexamethasone suppression test in patients with post-psychotic depression. Biol Psychiatry 1984; 19: 1351–1356.PubMedGoogle Scholar
  20. Spitzer Rl, Endiwtt J, Robins E. Research Diagnostic Criteria: Rationale and reliability. Arch Gen Psychiatry 1978; 35: 773–782.Google Scholar
  21. Tsuang Mt. Suicide in schizophrenics, manics, depressives, and surgical controls. Arch Gen Psychiatry 1978; 35: 153–155.PubMedCrossRefGoogle Scholar
  22. Wilkinson DG. The suicide rate in schizophrenia. Br J Psychiatry 1982; 140: 138–141.PubMedCrossRefGoogle Scholar
  23. Wolkowitz OM, Pickar D, Doran AR, et al. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. Am J Psychiatry 1986; 142: 85–87.Google Scholar

Copyright information

© Friedr. Vieweg Verlag, Braunschweig/Wiesbaden 1990

Authors and Affiliations

  • A. Rifkin
  • S. G. Siris

There are no affiliations available

Personalised recommendations